Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Resectable Breast Cancer”

Showing 3 of 0 results

Large-scale testing (Phase 3)Looking for participantsNCT07441460
What this trial is testing

A Phase III Study of KN026 in Combination With HB1801 as Adjuvant Therapy for Resectable HER2-Positive Breast Cancer

Who this might be right for
Resectable HER2-positive Breast Cancer
Shanghai JMT-Bio Inc. 1,800
Testing effectiveness (Phase 2)Looking for participantsNCT03815890
What this trial is testing

Pre-operative Trial for Breast Cancer With Nivolumab in Combination With Novel IO

Who this might be right for
Breast Cancer
The Netherlands Cancer Institute 80
Testing effectiveness (Phase 2)WithdrawnNCT01679743
What this trial is testing

GRN1005 for Brain Metastases From Breast or Lung Cancer

Who this might be right for
Breast CancerLung NeoplasmsBreast Neoplasms+1 more
National Cancer Institute (NCI)

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation